News about DiCE
Strengthening Patient Representation at UEG Week 2026
At UEG Week 2026 in Barcelona, DiCE strengthened patient representation, championed cancer prevention and early detection, and shared new TOGAS res...
The EU Biotech Act: What an Extra Year of IP Rights Could Mean for Patients
Could an extra year of protection for some medicines bring new cancer treatments closer, or delay more affordable options? As Europe debates the EU...
Funding Member Organisations to Make a Greater Impact Across Europe
DiCE’s 2026 operational grants and Wolfram Nolte Memorial Award offer Member Organisations flexible funding to strengthen patient-led work across...
Strengthening the Voice of Liver Cancer Patients: Welcoming the Croatian Rare Liver Foundation to DiCE
The Croatian Rare Liver Foundation has joined DiCE, strengthening the voice of people affected by liver cancer in Croatia. Its expertise in patient...
How US Drug Pricing Could Affect Access to Cancer Medicines in Europe
US drug pricing reforms could influence when and where cancer medicines reach European patients. Evidence remains inconclusive, but concerns over d...
Learning Together to Improve Lives: Highlights from the 11th DiCE Masterclass 2026
The 11th DiCE Masterclass brought together patient advocates, healthcare professionals, and researchers to explore the latest advances in digestive...
213 People Turning Awareness into Action at the Fun Run in Munich
A vibrant community came together in Munich as 213 participants walked and ran to raise awareness of digestive cancers, celebrating movement, conne...
Europe’s Colorectal Cancer Screening Gap: New Index Reveals Who Is Being Left Behind
The 2026 European Cancer Screening Policy Index reveals major disparities in colorectal cancer screening across Europe, reinforcing the need for eq...
ECO-POP Advances a New Vision for Personalised Colorectal Cancer Care
Partners from the ECO-POP project gathered in Oslo to review progress on three innovative colorectal cancer trials exploring more personalised, les...